Providence's Sherry Bucholz is announced recipient of the 2023 Debra L. Dooley GME Program Coordinator Excellence Award

Providence is proud to announce Diagnostic Radiology Program Coordinator, Sherry Bucholz, has been recognized by the Accreditation Council for Graduate Medical Education (ACGME), as a recipient of the 2023 Debra L. Dooley GME Program Coordinator Excellence Award.

The ACGME Awards Program recognizes notable designated institutional officials, program directors, coordinators, and residents and fellows for their outstanding work and contributions to graduate medical education through its Awards Program.

“The award recipients truly embody this year’s conference theme, Meaning in Medicine: Making a Difference, and have made immeasurable contributions to the graduate medical education community. We are proud to have such accomplished individuals and programs supporting the medical education continuum while navigating a great deal of uncertainty,” said ACGME President and Chief Executive Officer Thomas J. Nasca, MD, MACP

Sherry was given the 2023 Debra L. Dooley GME Program Coordinator Excellence Award. This award recognizes program coordinators for their in-depth understanding of the accreditation process, excellent communication and interpersonal skills, and projects to improve residency programs.

Congratulations Sherry! You deserve it.

Providence reports Q3 2024 results
11/26/2024
Providence announced results for the three months ended September 30, 2024. The not-for-profit health system continued to improve performance while serving more people in need.
Two clinical trials for solid tumor cancers take different approaches to stop growth
11/22/2024
Two global studies open at Providence Cancer Institute will evaluate combinations of medications to help stop or slow the growth of cancer in solid tumors.
Providence names Darryl A. Elmouchi, M.D., next chief operating officer
11/19/2024
Providence selects Darryl A. Elmouchi, M.D., MBA, as its new chief operating officer, effective Jan. 2.
Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says  
Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice
Powered by Translations.com GlobalLink Web SoftwarePowered by GlobalLink Web